Locally Advanced Cervical Cancer Clinical Trial
Official title:
An Initial Feasibility Study to Integrate High-precision, Image Guided, Radiotherapy(MRI Based Brachytherapy and CT/MRI Fused Dynamic IMRT Planning) in the Treatment Planning of 10 Patients With Locally Advanced Carcinoma of the Cervix
Main cause of mortality in cervix cancer is local relapse in the pelvis. Since distant metastasis is quiet rare, increasing local control in the pelvis can directly translate into improvement in survival. Obstacles in front of this approach is the dose limitation to normal organs located in the pelvis adjacent to the tumor. 3-D MRI based EBRT and Brachytherapy will grant safe delivery of more conformal higher doses of radiation to the tumor and allowing sparing of the normal structures.
A total of 10 patients with a diagnosis of locally advanced cervical carcinoma will be enrolled. After diagnosis and written informed consent, patients will undergo investigations prior to treatment planning, including CT imaging as per standard of care. In addition, patients will have an MRI of the pelvis + PET scan + EUA and gold seeds insertion to verify pelvic organs movement and EB-IMRT with daily cone beam CT. Brachytherapy treatment planning will be based on MRI imaging with the applicator in situ. ;
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT03225443 -
Observation and Evaluation of Short-term Curative Effect of Local Advanced Cervical Cancer Treated With Particle Radiotherapy Versus Neoadjuvant Chemotherapy
|
N/A | |
Recruiting |
NCT06079671 -
Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)
|
Phase 3 | |
Completed |
NCT05059119 -
Rectovaginal Fistula in Post-Radiotherapy Advanced Cervical Cancer Patients
|
||
Recruiting |
NCT06055738 -
Zimberelimab Combined With Albumin-bound Paclitaxel and Cisplatin in Neoadjuvant Treatment of LACC
|
Phase 2 | |
Recruiting |
NCT06156514 -
Evaluation of Concomitant Chemo-radiotherapy With Cisplatine vs Gemcitabin in Locally Advanced Cervicouterine Cancer
|
Phase 3 | |
Completed |
NCT03298893 -
Nivolumab in Association With Radiotherapy and Cisplatin in Locally Advanced Cervical Cancers Followed by Adjuvant Nivolumab for up to 6 Months
|
Phase 1/Phase 2 | |
Recruiting |
NCT05950087 -
Study on the Relationship Between Plasma MRD and cfDNA HPV and the Efficacy and Prognosis of Locally Advanced Cervical Cancer After Concurrent Chemoradiotherapy
|
||
Recruiting |
NCT04884906 -
Camrelizumab Combined With Radiotherapy and Chemotherapy for the Treatment of Recurrent or Metastatic Cervical Cancer
|
Phase 2 | |
Not yet recruiting |
NCT05799469 -
Study of Chemoradiotherapy With Envafolimab For The Treatment of Locally Advanced Cervical Cancer
|
Phase 2 | |
Recruiting |
NCT05311566 -
PD-1 Antibody Plus Chemoradiotherapy for IB2-IIIB Cervical Cancer
|
Phase 2 | |
Terminated |
NCT02045433 -
Stereotactic Body Radiation Therapy (SABR) for Definitive Treatment of Locally Advanced Cervical Cancer
|
Phase 2 | |
Recruiting |
NCT06237257 -
A Study of Chemoradiotherapy With SHR-1316 For Treatment of Locally Advanced Cervical Cancer
|
Phase 2 | |
Not yet recruiting |
NCT06288360 -
Neoadjuvant Immunochemotherapy in PD-L1-negative LACC
|
Phase 2 | |
Not yet recruiting |
NCT06288373 -
Neoadjuvant Chemoimmunotherapy Versus Concurrent Chemoradiotherapy for LACC
|
Phase 2/Phase 3 | |
Recruiting |
NCT06068387 -
A Prospective Study on the Prediction Model of Para-aortic Lymph Node Metastasis
|
N/A | |
Recruiting |
NCT05378087 -
Comparing the Efficacy of Surgery Staging and Image Staging of Locally Advanced Cervical Cancer
|
N/A | |
Recruiting |
NCT03963882 -
NAC Followed by RH for the Treatment of LACC
|
Phase 2 | |
Recruiting |
NCT01938105 -
Preoperative Chemoradiotherapy Combined With Nimotuzumab for Cervical Cancer
|
Phase 2 | |
Active, not recruiting |
NCT01793701 -
Intensity-modulated Radiotherapy for Locally Advanced Cervical Cancer
|
Phase 1/Phase 2 | |
Completed |
NCT01230996 -
Dose Escalation Study of Simultaneous Boost Intensity-Modulated Radiotherapy for Locally Advanced Cervical Cancer
|
Phase 1/Phase 2 |